- Report
- June 2024
- 85 Pages
India
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- May 2024
- 182 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- April 2024
- 187 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- April 2024
- 180 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- February 2024
- 186 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
- Report
- February 2024
- 170 Pages
Global
From €3370EUR$3,825USD£2,904GBP
€3965EUR$4,500USD£3,416GBP
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- November 2023
- 77 Pages
Germany
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- November 2023
- 88 Pages
France
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- October 2023
- 70 Pages
Canada
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- October 2023
- 83 Pages
Israel
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- August 2023
- 74 Pages
United States
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- August 2023
- 74 Pages
Israel
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- March 2022
- 76 Pages
Saudi Arabia
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- April 2023
- 111 Pages
Global
From €4185EUR$4,750USD£3,606GBP
- Report
- December 2024
- 83 Pages
Saudi Arabia
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP
- Report
- July 2024
- 80 Pages
Japan
From €2621EUR$2,975USD£2,259GBP
€3084EUR$3,500USD£2,657GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more